Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Curcumin vs HPR Plus for Radiation Dermatitis in Breast Cancer
NCT02556632Phase 2Completed
- Start
- Oct 2015
- Primary completion
- Sep 2016
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of curcumin in radiation dermatitis (3 arms). Primary endpoints: Mean Radiation Dermatitis Severity Score, Incidence of Moist Desquamation and 1 more. Started Oct 2015; status: completed.
02
Drugs
curcumin
03
Conditions
radiation dermatitis
Beyond the preview
Go deeper on NCT02556632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02556632.